Monthly Archives: October 2013

Catching Up on Google+ and Pharma

Posted on October 29, 2013 by Mark Senak

Back in 2011 when Google+ emerged from Beta and started offering branded pages, there was a good deal of commentary in the blogosphere about the potential use for the new platform by pharma – even here at Eye on FDA. … Continue reading →

Posted in Social Media | Comments Off on Catching Up on Google+ and Pharma

Weekly Roundup – 10-25-13

Posted on October 25, 2013 by Mark Senak

Well, there is definitely a bite of autumn crispness in the air and I think we are on the verge of first frost.  The days are noticeably shorter. Daylight savings (always thought it a funny name for it) is upon … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 10-25-13

Warning and NOV Letter Summary – 3rd Quarter 2013

Posted on October 15, 2013 by Mark Senak

Government shut down or no government shut down, the read for Warning and NOV letters out of the Office of Prescription Drug Promotion (OPDP) is slim pickings. It is always a good idea at the end of the quarter to … Continue reading →

Posted in Warning Letters | Comments Off on Warning and NOV Letter Summary – 3rd Quarter 2013

Weekly Roundup – 10-11-13

Posted on October 11, 2013 by Mark Senak

For Washington, it is real quiet.  This week on my way to work while driving past the Lincoln Memorial, there was a man with a lawn mower unofficially mowing the lawn.  The Federal Register which reports on all of the … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 10-11-13

AdComms and the #Shutdown

Posted on October 9, 2013 by Mark Senak

People are looking for black and white answers about what government agencies in general are going to do during the shutdown respecting specific operations.  One of the specific areas of interest at FDA has been whether or not there will … Continue reading →

Posted in Advisory Committee Prepapartion, Current Affairs | Comments Off on AdComms and the #Shutdown